SkyePharma, Sanofi sales and marketing update

SKP partner Sanofi-Synthelabo launched Xatral XL sustained release once daily formulation of alfuzosin in Europe and the U.K. to treat symptoms of benign prostatic hypertrophy. The product uses SKP's...